Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Conjugate Vaccines Market Research Report 2021

  • QYR660796
  • 102 Pages
  • August 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Conjugate Vaccines

Revenue, means the sales value of Conjugate Vaccines

This report studies Conjugate Vaccines in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

Astellas Pharma Inc

CSL Limited

Emergent BioSolutions, Inc

GlaxoSmithKline

Johnson & Johnson

MedImmune, LLC

Merck & Co

Pfizer

Sanofi Pasteur

Serum Institute

India Pvt. Ltd. (India)

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Conjugate Vaccines in these regions, from 2011 to 2021 (forecast), like

North America

China

Europe

Japan

India

Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Pneumococcal

Influenza

HPV

Hepatitis

Rotavirus

DTP

Polio

MMR

Split by application, this report focuses on sales, market share and growth rate of Conjugate Vaccines in each application, can be divided into

Pediatric

Adult

Application 3

Table of Contents

Global Conjugate Vaccines Market Research Report 2021

1 Conjugate Vaccines Overview

1.1 Product Overview and Scope of Conjugate Vaccines

1.2 Conjugate Vaccines Segment by Types

1.2.1 Global Sales Market Share of Conjugate Vaccines by Type in 2015

1.2.2 Pneumococcal

1.2.3 Influenza

1.2.4 HPV

1.2.5 Hepatitis

1.2.6 Rotavirus

1.2.7 DTP

1.2.8 Polio

1.2.9 MMR

1.3 Conjugate Vaccines Segment by Applications

1.3.1 Pediatric

1.3.2 Adult

1.3.3 Application 3

1.4 Conjugate Vaccines Market by Regions

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Conjugate Vaccines (2011-2021)

1.5.1 Global Conjugate Vaccines Sales and Revenue (2011-2021)

1.5.2 Global Conjugate Vaccines Sales and Growth Rate (2011-2021)

1.5.3 Global Conjugate Vaccines Revenue and Growth Rate (2011-2021)

2 Global Conjugate Vaccines Market Competition by Manufacturers

2.1 Global Conjugate Vaccines Sales and Share by Manufacturers (2015 and 2016)

2.2 Global Conjugate Vaccines Revenue and Share by Manufacturers (2015 and 2016)

2.3 Manufacturers Conjugate Vaccines Manufacturing Base Distribution and Product Type

2.4 Competitive Situation and Trends

2.4.1 Expansions

2.4.2 New Product Launches

2.4.3 Acquisitions

2.4.4 Other Developments

3 Global Conjugate Vaccines Analysis by Region

3.1 Global Conjugate Vaccines Sales, Revenue and Market Share by Region (2011-2021)

3.1.1 Global Conjugate Vaccines Sales Market Share by Region (2011-2021)

3.1.2 Global Conjugate Vaccines Revenue Market Share by Region (2011-2021)

3.2 North America

3.2.1 North America Conjugate Vaccines Sales, Revenue and Price (2011-2021)

3.2.2 North America Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.3 Europe

3.3.1 Europe Conjugate Vaccines Sales, Revenue and Price (2011-2021)

3.3.2 Europe Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.4 China

3.4.1 China Conjugate Vaccines Sales, Revenue and Price (2011-2021)

3.4.2 China Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.5 Japan

3.5.1 Japan Conjugate Vaccines Sales, Revenue and Price (2011-2021)

3.5.2 Japan Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.6 India

3.6.1 India Conjugate Vaccines Sales, Revenue and Price (2011-2021)

3.6.2 India Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.7 Southeast Asia

3.7.1 Southeast Asia Conjugate Vaccines Sales, Revenue and Price (2011-2021)

3.7.2 Southeast Asia Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

4 Global Conjugate Vaccines Analysis by Type

4.1 Global Conjugate Vaccines Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)

4.1.1 Global Conjugate Vaccines Sales and Market Share by Type (2011-2021)

4.1.2 Global Conjugate Vaccines Revenue, Market Share and Growth Rate by Type (2011-2021)

4.2 Pneumococcal Sales, Revenue, Price and Growth (2011-2021)

4.3 Influenza Sales, Revenue, Price and Growth (2011-2021)

4.4 HPV Sales, Revenue, Price and Growth (2011-2021)

4.5 Hepatitis Sales, Revenue, Price and Growth (2011-2021)

4.6 Rotavirus Sales, Revenue, Price and Growth (2011-2021)

4.7 DTP Sales, Revenue, Price and Growth (2011-2021)

4.8 Polio Sales, Revenue, Price and Growth (2011-2021)

4.9 MMR Sales, Revenue, Price and Growth (2011-2021)

5 Global Conjugate Vaccines Market Analysis by Application

5.1 Global Conjugate Vaccines Sales and Market Share by Application (2011-2021)

5.2 Major Regions Conjugate Vaccines Sales by Application in 2015 and 2016

5.2.1 North America Conjugate Vaccines Sales by Application

5.2.2 Europe Conjugate Vaccines Sales by Application

5.2.3 China Conjugate Vaccines Sales by Application

5.2.4 Japan Conjugate Vaccines Sales by Application

5.2.5 India Conjugate Vaccines Sales by Application

5.2.6 Southeast Asia Conjugate Vaccines Sales by Application

6 Global Conjugate Vaccines Manufacturers Analysis

6.1 Astellas Pharma Inc

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Conjugate Vaccines Product Overview

6.1.2.1 Pneumococcal

6.1.2.2 Influenza

6.1.2.3 HPV

6.1.3 Conjugate Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

6.2 CSL Limited

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Conjugate Vaccines Product Overview

6.2.2.1 Pneumococcal

6.2.2.2 Influenza

6.2.2.3 HPV

6.2.3 Conjugate Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)

6.3 Emergent BioSolutions, Inc

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Conjugate Vaccines Product Overview

6.3.2.1 Pneumococcal

6.3.2.2 Influenza

6.3.2.3 HPV

6.3.3 Conjugate Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

6.4 GlaxoSmithKline

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Conjugate Vaccines Product Overview

6.4.2.1 Pneumococcal

6.4.2.2 Influenza

6.4.3 Conjugate Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

6.5 Johnson & Johnson

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Conjugate Vaccines Product Overview

6.5.2.1 Pneumococcal

6.5.2.2 Influenza

6.5.3 Conjugate Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

6.6 MedImmune, LLC

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Conjugate Vaccines Product Overview

6.6.2.1 Pneumococcal

6.6.2.2 Influenza

6.6.3 Conjugate Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

6.7 Merck & Co

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Conjugate Vaccines Product Overview

6.7.2.1 Pneumococcal

6.7.2.2 Influenza

6.7.3 Conjugate Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)

6.8 Pfizer

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Conjugate Vaccines Product Overview

6.8.2.1 Pneumococcal

6.8.2.2 Influenza

6.8.3 Conjugate Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)

6.9 Sanofi Pasteur

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Conjugate Vaccines Product Overview

6.9.2.1 Pneumococcal

6.9.2.2 Influenza

6.9.3 Conjugate Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

6.10 Serum Institute

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Conjugate Vaccines Product Overview

6.10.2.1 Pneumococcal

6.10.2.2 Influenza

6.10.3 Conjugate Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)

6.11 India Pvt. Ltd. (India)

7 Industry Policy Analysis

8 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Conjugate Vaccines

Figure Global Sales Market Share of Conjugate Vaccines by Type in 2015

Table Conjugate Vaccines Product Type of by Manufacturers

Table Conjugate Vaccines Sales Market Share by Application in 2015 and 2016

Figure North America Conjugate Vaccines Revenue and Growth Rate (2011-2021)

Figure China Conjugate Vaccines Revenue and Growth Rate (2011-2021)

Figure Europe Conjugate Vaccines Revenue and Growth Rate (2011-2021)

Figure Japan Conjugate Vaccines Revenue and Growth Rate (2011-2021)

Figure India Conjugate Vaccines Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Conjugate Vaccines Revenue and Growth Rate (2011-2021)

Table Global Conjugate Vaccines Sales and Revenue (2011-2021)

Figure Global Conjugate Vaccines Sales and Growth Rate (2011-2021)

Figure Global Conjugate Vaccines Revenue and Growth Rate (2011-2021)

Table Global Conjugate Vaccines Sales of Key Manufacturers (2015 and 2016)

Table Global Conjugate Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Conjugate Vaccines Sales Share by Manufacturers

Figure 2016 Conjugate Vaccines Sales Share by Manufacturers

Table Global Conjugate Vaccines Revenue by Manufacturers (2015 and 2016)

Table Global Conjugate Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Conjugate Vaccines Revenue Share by Manufacturers

Table 2016 Global Conjugate Vaccines Revenue Share by Manufacturers

Table Manufacturers Conjugate Vaccines Manufacturing Base Distribution and Product Type

Table Global Conjugate Vaccines Sales Market by Region (2011-2021)

Figure Global Conjugate Vaccines Sales Market by Region (2011-2021)

Figure Global Conjugate Vaccines Sales Market Share by Region (2011-2021)

Table Global Conjugate Vaccines Revenue Market by Region (2011-2021)

Table Global Conjugate Vaccines Revenue Market Share by Region (2011-2021)

Table North America Conjugate Vaccines Sales, Revenue and Price (2011-2021)

Figure North America Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Europe Conjugate Vaccines Sales, Revenue and Price (2011-2021)

Figure Europe Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table China Conjugate Vaccines Sales, Revenue and Price (2011-2021)

Figure China Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Japan Conjugate Vaccines Sales, Revenue and Price (2011-2021)

Figure Japan Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table India Conjugate Vaccines Sales, Revenue and Price (2011-2021)

Figure India Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Southeast Asia Conjugate Vaccines Sales, Revenue and Price (2011-2021)

Figure Southeast Asia Conjugate Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Global Conjugate Vaccines Sales by Type (2011-2021)

Table Global Conjugate Vaccines Sales Share by Type (2011-2021)

Figure Sales Market Share of Conjugate Vaccines by Type (2011-2021)

Figure Global Conjugate Vaccines Sales Growth Rate by Type (2011-2021)

Table Global Conjugate Vaccines Revenue by Type (2011-2021)

Table Global Conjugate Vaccines Revenue Share by Type (2011-2021)

Figure Global Conjugate Vaccines Revenue Growth Rate by Type (2011-2021)

Figure Pneumococcal Sales, Revenue and Growth (2011-2021)

Figure Pneumococcal Price Trend (2011-2021)

Figure Influenza Sales, Revenue and Growth (2011-2021)

Figure Influenza Price Trend (2011-2021)

Figure HPV Sales, Revenue and Growth (2011-2021)

Figure HPV Price Trend (2011-2021)

Figure Hepatitis Sales, Revenue and Growth (2011-2021)

Figure Hepatitis Price Trend (2011-2021)

Figure Rotavirus Sales, Revenue and Growth (2011-2021)

Figure Rotavirus Price Trend (2011-2021)

Figure DTP Sales, Revenue and Growth (2011-2021)

Figure DTP Price Trend (2011-2021)

Figure Polio Sales, Revenue and Growth (2011-2021)

Figure Polio Price Trend (2011-2021)

Figure MMR Sales, Revenue and Growth (2011-2021)

Figure MMR Price Trend (2011-2021)

Table Global Conjugate Vaccines Sales by Application (2011-2021)

Table Global Conjugate Vaccines Sales Market Share by Application (2011-2021)

Figure Global Conjugate Vaccines Sales Market Share by Application in 2015

Figure Global Conjugate Vaccines Sales Market Share by Application in 2021

Table North America Conjugate Vaccines Sales by Application (2015 and 2016)

Table Europe Conjugate Vaccines Sales by Application (2015 and 2016)

Table China Conjugate Vaccines Sales by Application (2015 and 2016)

Table Japan Conjugate Vaccines Sales by Application (2015 and 2016)

Table India Conjugate Vaccines Sales by Application (2015 and 2016)

Table Southeast Asia Conjugate Vaccines Sales by Application (2015 and 2016)

Table Global Conjugate Vaccines Sales Growth Rate by Application (2011-2021)

Figure Global Conjugate Vaccines Sales Growth Rate by Application (2011-2021)

Table Astellas Pharma Inc Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

Table CSL Limited Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)

Table Emergent BioSolutions, Inc Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table MedImmune, LLC Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

Table Merck & Co Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)

Table Pfizer Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Sanofi Pasteur Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

Table Serum Institute Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)

Table India Pvt. Ltd. (India) Basic Information List

Table Conjugate Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390